Expression and/or activity of the SVCT2 ascorbate transporter may be decreased in many aggressive cancers, suggesting potential utility for sodium bicarbonate and dehydroascorbic acid in cancer therapy. - 0 views
-
Nathan Goodyear on 03 Jun 19To be fully read later.